Tadocizumab Biosimilar (Integrin a2b3 (ITGA2 & ITGB3) Reference Antibody)
Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research.
Product Specifications
Target
Tadocizumab Biosimilar (Anti-Integrin a2b3 (ITGA2 & ITGB3) Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Neuroscience; Immunology & Inflammation
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SM1707 250 µg
B2m mouse monoclonal antibody, clone TLD-3H12B, Purified
Sign In for Pricing
View Details 033493-AP 200 µL
CD31, CT (Pecam1, Pecam, Pecam-1, Platelet endothelial cell adhesion molecule, CD31) (AP) discontinued
Sign In for Pricing
View Details 